FindTrial
Sign In

"Explorative triple-arm dosis-finding study for examination about the effectivity and tolerance of Bromelain by acute sinusitis" - Effectivity of different dosis of Bromelain by sinusitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-005654-53-DE
Enrollment
Unknown
Registered
2006-10-05
Start date
2006-12-07
Completion date
Unknown
Last updated
2012-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Therapy of acute sinusitis

Interventions

Trade Name: Bromelain-POS(R) Product Name: Bromelain-POS(R) Pharmaceutical Form: Gastro-resistant tablet INN or Proposed INN: L8.L CAS Number: 9001-007 Concentration unit: mg milligram(s) Concentratio

Sponsors

Ursapharm Arzneimittel GmbH & Co. KG
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: male and female patients with acute sinusitis Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: chronical sinusitis, symptoms of allergic rhinitis/sinusitis, pregnancy, nursing women

Design outcomes

Primary

MeasureTime frame
Main Objective: time of cure;Secondary Objective: improvement of the state of health from the hole population;Primary end point(s): time of cure—

Countries

Germany

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026